Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change

Year-over-year net income growth rate

Latest
-49.07%
↑ 12% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-56.04%
Historical baseline
PeriodValue
2024-49.07%
2023-13.39%
2022-27.04%
2021-96.65%
2020-35.70%
2019-170.46%
20180.00%